T834-1344 Screening compound: N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

T834-1344 Screening compound: N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide
T834-1344 Screening compound: N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T834-1344
N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T834-1344

Molecular Formula

C24H30N6O2 (C24 H30 N6 O2)

Compound Name

N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H,5H-pyrazolo[1,5-a]quinoxaline-2-carboxamide

IUPAC name

N-methyl-N-[(3-methyl-1-propyl-1H-pyrazol-5-yl)methyl]-5-(2-methylpropyl)-4-oxo-4H5H-pyrazolo[15-a]quinoxaline-2-carboxamide

SMILES

CCCn1nc(C)cc1CN(C)C(c(cc12)nn1-c(cccc1)c1N(CC(C)C)C2=O)=O

InChI

InChI=1S/C24H30N6O2/c1-6-11-29-18(12-17(4)25-29)15-27(5)23(31)19-13-22-24(32)28(14-16(2)3)20-9-7-8-10-21(20)30(22)26-19/h7-10,12-13,16H,6,11,14-15H2,1-5H3

InChI Key

SELTWJUCOYVWOB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29031264

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.016

Distribution Coefficient, logD

3.016

Water Solubility, LogSw

-3.25

Polar Surface Area

57.622

Acid Dissociation Constant (pKa)

25.05

Base Dissociation Constant (pKb)

0.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

T834-1344 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with T834-1344 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T834-1344?
Check Price and Availability of T834-1344, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T834-1344 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T834-1344
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T834-1344
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T834-1344 available by request